Chen, Z., Li, F., Chen, C. (2026). TRIUNITE-02: A phase 2, open-label, randomized study of neoadjuvant CAPEOX plus tislelizumab and chidamide versus CAPEOX alone in previously untreated, resectable, locally advanced mismatch repair-proficient/microsatellite stable colon cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.tps261